We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“As the flu season overlaps with the second wave of COVID-19, there is an increasing need to be able to quickly distinguish between SARS-CoV-2 and influenza infections,” said Wolfgang Schlumberger, CEO of Euroimmun. Read More
“Successful exploitation of these vulnerabilities together could result in the attacker being able to modify or fabricate data from the implanted cardiac device being uploaded to the CareLink Network and remotely execute code … which could allow control of a paired cardiac device,” DHS warned. Read More
“Healthcare providers can use this personalized risk information to make more informed decisions about the use of oral opioids for acute pain when developing pain management plans for their patients,” SOLVD said. Read More
Atara will receive an initial $60 million from Bayer and is eligible to receive an additional $610 million and tiered royalties in milestone-based payments. Read More
“The ability to test saliva samples for the presence of SARS-CoV-2 … simplifies the sample collection process and streamlines the testing workflow, while reducing the exposure of medical personnel to potentially infected individuals,” the company said. Read More